JAMA:低剂量“神药”阿司匹林预防子痫及相关发病率和死亡率

2021-10-05 MedSci原创 MedSci原创

子痫前期是影响孕妇的最严重的健康问题之一。

子痫前期是影响孕妇的最严重的健康问题之一。它是一种多系统的炎症综合征,通常是渐进式的,但病因不明确。在世界范围内,子痫前期是孕产妇发病和死亡的第二大原因。在美国,它是大约4%的妊娠的并发症,并导致产妇和婴儿的发病率和死亡率。子痫前期还占美国6%的早产和19%的医学指示性早产。

子痫前期的发病率和死亡率存在着种族和民族的差异。非西班牙裔黑人妇女患子痫前期的风险比其他妇女大,而且母婴发病率和围产期死亡率比其他种族和族裔群体高。在美国,非西班牙裔黑人妇女死于子痫前期的比率高于非西班牙裔白人妇女。

为了更新其2014年的建议,美国预防服务工作组(USPSTF)委托进行了一项系统性审查,以评估使用低剂量阿司匹林预防子痫前期的有效性。该研究选用有先兆子痫高风险的孕妇,且之前没有使用低剂量阿司匹林的不良反应或禁忌症。

有前次怀孕的子痫前期病史、1型或2型糖尿病、以及慢性高血压的人患子痫前期的风险最高。其他使人处于子痫前期高风险的情况包括多胎妊娠、使用辅助生殖技术受孕、自身免疫性疾病和肾脏疾病。其他与子痫前期风险增加有关的因素包括:无生育能力,怀孕前身体质量指数高,有子痫前期的家族史,以及产妇年龄大(35岁或以上)。此外,由于各种社会和健康方面的不平等,黑人患子痫前期的比例较高,而且出现严重并发症的风险也增加了。

使用阿司匹林预防子痫前期及相关发病率和死亡率

证据评估 USPSTF得出中等程度的结论,即每日使用低剂量阿司匹林对降低子痫前期、早产、小胎龄/宫内生长受限以及子痫前期高危孕妇围产期死亡的风险有很大的净效益。

为此,USPSTF建议妊娠12周后的子痫前期高危人群使用低剂量阿司匹林(81mg/d)作为子痫前期的预防用药。

参考文献:

US Preventive Services Task Force. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;326(12):1186–1191. doi:10.1001/jama.2021.14781

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1823757, encodeId=286b1823e5724, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sat Aug 20 12:26:05 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068206, encodeId=35c210682061f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10b65509612, createdName=小雨闲, createdTime=Mon Nov 08 19:38:30 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067440, encodeId=8b75106e44019, content=鼓励一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/493f0df1d64843c08a6b82df2ec3a16e/9b4a8ab3a3304eac957cba27a4779183.jpeg, createdBy=76aa3806739, createdName=Mario, createdTime=Fri Nov 05 23:39:38 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735632, encodeId=d6b21e3563222, content=<a href='/topic/show?id=1ed3100299d2' target=_blank style='color:#2F92EE;'>#预防子痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100299, encryptionId=1ed3100299d2, topicName=预防子痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca7a33920950, createdName=qblt, createdTime=Wed Nov 10 15:26:05 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058351, encodeId=37f0105835127, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:29:22 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480609, encodeId=d17114806096b, content=<a href='/topic/show?id=647d2615939' target=_blank style='color:#2F92EE;'>#低剂量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26159, encryptionId=647d2615939, topicName=低剂量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97b17641126, createdName=ms1292405679162969, createdTime=Thu Oct 07 13:26:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058040, encodeId=bfd01058040d4, content=很棒的软件, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f255526204, createdName=我思故我在2, createdTime=Wed Oct 06 08:47:35 CST 2021, time=2021-10-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1823757, encodeId=286b1823e5724, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sat Aug 20 12:26:05 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068206, encodeId=35c210682061f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10b65509612, createdName=小雨闲, createdTime=Mon Nov 08 19:38:30 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067440, encodeId=8b75106e44019, content=鼓励一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/493f0df1d64843c08a6b82df2ec3a16e/9b4a8ab3a3304eac957cba27a4779183.jpeg, createdBy=76aa3806739, createdName=Mario, createdTime=Fri Nov 05 23:39:38 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735632, encodeId=d6b21e3563222, content=<a href='/topic/show?id=1ed3100299d2' target=_blank style='color:#2F92EE;'>#预防子痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100299, encryptionId=1ed3100299d2, topicName=预防子痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca7a33920950, createdName=qblt, createdTime=Wed Nov 10 15:26:05 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058351, encodeId=37f0105835127, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:29:22 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480609, encodeId=d17114806096b, content=<a href='/topic/show?id=647d2615939' target=_blank style='color:#2F92EE;'>#低剂量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26159, encryptionId=647d2615939, topicName=低剂量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97b17641126, createdName=ms1292405679162969, createdTime=Thu Oct 07 13:26:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058040, encodeId=bfd01058040d4, content=很棒的软件, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f255526204, createdName=我思故我在2, createdTime=Wed Oct 06 08:47:35 CST 2021, time=2021-10-06, status=1, ipAttribution=)]
    2021-11-08 小雨闲

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1823757, encodeId=286b1823e5724, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sat Aug 20 12:26:05 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068206, encodeId=35c210682061f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10b65509612, createdName=小雨闲, createdTime=Mon Nov 08 19:38:30 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067440, encodeId=8b75106e44019, content=鼓励一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/493f0df1d64843c08a6b82df2ec3a16e/9b4a8ab3a3304eac957cba27a4779183.jpeg, createdBy=76aa3806739, createdName=Mario, createdTime=Fri Nov 05 23:39:38 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735632, encodeId=d6b21e3563222, content=<a href='/topic/show?id=1ed3100299d2' target=_blank style='color:#2F92EE;'>#预防子痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100299, encryptionId=1ed3100299d2, topicName=预防子痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca7a33920950, createdName=qblt, createdTime=Wed Nov 10 15:26:05 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058351, encodeId=37f0105835127, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:29:22 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480609, encodeId=d17114806096b, content=<a href='/topic/show?id=647d2615939' target=_blank style='color:#2F92EE;'>#低剂量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26159, encryptionId=647d2615939, topicName=低剂量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97b17641126, createdName=ms1292405679162969, createdTime=Thu Oct 07 13:26:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058040, encodeId=bfd01058040d4, content=很棒的软件, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f255526204, createdName=我思故我在2, createdTime=Wed Oct 06 08:47:35 CST 2021, time=2021-10-06, status=1, ipAttribution=)]
    2021-11-05 Mario

    鼓励一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1823757, encodeId=286b1823e5724, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sat Aug 20 12:26:05 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068206, encodeId=35c210682061f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10b65509612, createdName=小雨闲, createdTime=Mon Nov 08 19:38:30 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067440, encodeId=8b75106e44019, content=鼓励一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/493f0df1d64843c08a6b82df2ec3a16e/9b4a8ab3a3304eac957cba27a4779183.jpeg, createdBy=76aa3806739, createdName=Mario, createdTime=Fri Nov 05 23:39:38 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735632, encodeId=d6b21e3563222, content=<a href='/topic/show?id=1ed3100299d2' target=_blank style='color:#2F92EE;'>#预防子痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100299, encryptionId=1ed3100299d2, topicName=预防子痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca7a33920950, createdName=qblt, createdTime=Wed Nov 10 15:26:05 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058351, encodeId=37f0105835127, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:29:22 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480609, encodeId=d17114806096b, content=<a href='/topic/show?id=647d2615939' target=_blank style='color:#2F92EE;'>#低剂量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26159, encryptionId=647d2615939, topicName=低剂量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97b17641126, createdName=ms1292405679162969, createdTime=Thu Oct 07 13:26:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058040, encodeId=bfd01058040d4, content=很棒的软件, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f255526204, createdName=我思故我在2, createdTime=Wed Oct 06 08:47:35 CST 2021, time=2021-10-06, status=1, ipAttribution=)]
    2021-11-10 qblt
  5. [GetPortalCommentsPageByObjectIdResponse(id=1823757, encodeId=286b1823e5724, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sat Aug 20 12:26:05 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068206, encodeId=35c210682061f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10b65509612, createdName=小雨闲, createdTime=Mon Nov 08 19:38:30 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067440, encodeId=8b75106e44019, content=鼓励一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/493f0df1d64843c08a6b82df2ec3a16e/9b4a8ab3a3304eac957cba27a4779183.jpeg, createdBy=76aa3806739, createdName=Mario, createdTime=Fri Nov 05 23:39:38 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735632, encodeId=d6b21e3563222, content=<a href='/topic/show?id=1ed3100299d2' target=_blank style='color:#2F92EE;'>#预防子痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100299, encryptionId=1ed3100299d2, topicName=预防子痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca7a33920950, createdName=qblt, createdTime=Wed Nov 10 15:26:05 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058351, encodeId=37f0105835127, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:29:22 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480609, encodeId=d17114806096b, content=<a href='/topic/show?id=647d2615939' target=_blank style='color:#2F92EE;'>#低剂量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26159, encryptionId=647d2615939, topicName=低剂量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97b17641126, createdName=ms1292405679162969, createdTime=Thu Oct 07 13:26:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058040, encodeId=bfd01058040d4, content=很棒的软件, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f255526204, createdName=我思故我在2, createdTime=Wed Oct 06 08:47:35 CST 2021, time=2021-10-06, status=1, ipAttribution=)]
    2021-10-07 老龙一点

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1823757, encodeId=286b1823e5724, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sat Aug 20 12:26:05 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068206, encodeId=35c210682061f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10b65509612, createdName=小雨闲, createdTime=Mon Nov 08 19:38:30 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067440, encodeId=8b75106e44019, content=鼓励一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/493f0df1d64843c08a6b82df2ec3a16e/9b4a8ab3a3304eac957cba27a4779183.jpeg, createdBy=76aa3806739, createdName=Mario, createdTime=Fri Nov 05 23:39:38 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735632, encodeId=d6b21e3563222, content=<a href='/topic/show?id=1ed3100299d2' target=_blank style='color:#2F92EE;'>#预防子痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100299, encryptionId=1ed3100299d2, topicName=预防子痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca7a33920950, createdName=qblt, createdTime=Wed Nov 10 15:26:05 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058351, encodeId=37f0105835127, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:29:22 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480609, encodeId=d17114806096b, content=<a href='/topic/show?id=647d2615939' target=_blank style='color:#2F92EE;'>#低剂量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26159, encryptionId=647d2615939, topicName=低剂量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97b17641126, createdName=ms1292405679162969, createdTime=Thu Oct 07 13:26:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058040, encodeId=bfd01058040d4, content=很棒的软件, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f255526204, createdName=我思故我在2, createdTime=Wed Oct 06 08:47:35 CST 2021, time=2021-10-06, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1823757, encodeId=286b1823e5724, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sat Aug 20 12:26:05 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068206, encodeId=35c210682061f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=10b65509612, createdName=小雨闲, createdTime=Mon Nov 08 19:38:30 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067440, encodeId=8b75106e44019, content=鼓励一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/493f0df1d64843c08a6b82df2ec3a16e/9b4a8ab3a3304eac957cba27a4779183.jpeg, createdBy=76aa3806739, createdName=Mario, createdTime=Fri Nov 05 23:39:38 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735632, encodeId=d6b21e3563222, content=<a href='/topic/show?id=1ed3100299d2' target=_blank style='color:#2F92EE;'>#预防子痫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100299, encryptionId=1ed3100299d2, topicName=预防子痫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca7a33920950, createdName=qblt, createdTime=Wed Nov 10 15:26:05 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058351, encodeId=37f0105835127, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:29:22 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1480609, encodeId=d17114806096b, content=<a href='/topic/show?id=647d2615939' target=_blank style='color:#2F92EE;'>#低剂量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26159, encryptionId=647d2615939, topicName=低剂量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=97b17641126, createdName=ms1292405679162969, createdTime=Thu Oct 07 13:26:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058040, encodeId=bfd01058040d4, content=很棒的软件, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2f255526204, createdName=我思故我在2, createdTime=Wed Oct 06 08:47:35 CST 2021, time=2021-10-06, status=1, ipAttribution=)]
    2021-10-06 我思故我在2

    很棒的软件

    0

相关资讯

AJOG:低剂量阿司匹林是否可降低高风险孕妇的子痫前期风险?

低剂量阿司匹林已经成为最研究广泛的子痫前期预防药物,它真的能降低高风险妊娠女性的子痫前期风险吗?

Br J Cancer:阿司匹林增强顺铂治疗食管鳞癌的疗效

食管癌(EC)作为中国第三大常见的癌症和第四大癌症死亡原因,据估计,每年有477,900例新发病例和375,000例死亡病例。

阿司匹林与消化道肿瘤——降低60%发病风险,提高一倍生存率!

阿司匹林诞生一百多年来,最先用于解热镇痛药,后来科学家对其研究发现越来越多的用途,小到解热镇痛,预防血栓,大到防治疗肿瘤。它是当之无愧的“神药”。本文简单介绍它在肿瘤防治方面的最新研究成果。

Diabetologia:利伐沙班 vs 阿司匹林可改善有高心血管风险的2型糖尿病患者的内皮功能,但会增加出血风险

与阿司匹林相比,利伐沙班可改善有亚临床炎症的 2 型糖尿病个体的内皮细胞功能,但也会增加出血风险。

JACC:双抗治疗怕出血?急性冠状动脉综合征DAPT降阶梯治疗的更佳方案来了!

在强效P2Y12抑制剂时代,平衡DAPT的效果已成为ACS管理的基石。。

救命药:救心丸、丹参滴丸、硝酸甘油、阿司匹林…千万别用错

在心脑血管病的治疗、预防和急救中,有四种药,我们最为熟悉:硝酸甘油、速效救心丸、丹参滴丸、阿司匹林。这几类究竟怎么用呢?

拓展阅读

阿司匹林抗癌原因找到了!研究发现:这些结直肠癌患者获益更大

近日,Cancer发表一项研究,表明结直肠癌患者使用阿司匹林,可能与较低的肿瘤分级和淋巴结转移,以及较高的肿瘤浸润有关。

阿司匹林天天用,这10个问题一定要知道!

长期服用阿司匹林,这10个问题一定要知道!

阿司匹林或可治脂肪肝!JAMA:近半数患者肝脏脂肪减少30%以上

该研究表明相比于安慰剂,每日使用低剂量的阿司匹林治疗6个月后,MASLD患者肝脏脂肪含量显著降低。未来有必要在更大的人群中开展进一步研究,以佐证本次研究的发现。

这种糖尿病并发症易被忽略,早期使用二甲双胍、他汀、阿司匹林或有益

近期,Diabetologia发表一项糖尿病与感染的综述,介绍了糖尿病与感染的双向关系,糖尿病患者常见的感染,以及对应的预防和治疗策略,以期为临床干预糖尿病感染提供洞见。

复旦大学余巍课题组《Adv. Sci.》:阿司匹林介导的SIRT1蛋白乙酰化可维持肠道免疫稳态

研究发现阿司匹林可以直接乙酰化修饰 SIRT1 蛋白的关键位点发挥其抗肿瘤和缓解肠道炎症的重要作用。

中药联合阿司匹林治疗复发性流产的疗效及安全性分析!

鉴于当前现代医学针对RSA的治疗存在明显不足,故中药联合阿司匹林可能提高妊娠率、孕期激素水平、ACA转阴率,降低孕妇的高凝状态、降低易栓症的发生,从而减少胎儿发育不良具有一定的效果。